Oraqix FAQ

At Stanley Dentistry, your comfort and dental health is the most important factor for us when treating you. No matter what procedures you may need done, we want to find ways to make the process as easy and as comfortable as possible. For that reason we use Oraqix for delivering localized anesthesia during some of our procedures. Below are some answers to our most frequently asked questions regarding Oraqix. If you have any questions that you feel we haven’t answered here, please contact us and we will respond to your comments directly.

Q: What is Oraqix used for?

A: Oraqix is indicated for adults who require localized anesthesia in periodontal pockets during scaling and/or root planing procedures.

Q: How does Oraqix work?

A: The active ingredients lidocaine base and prilocaine base in Oraqix anesthesia the nerves in the gingival margin and periodontal pockets where it is applied without the use of shots

Q: How long do I have wait before the anesthetize takes effect?

A: Treatment can begin 60 seconds after application.

Q: Will Oraqix numb the surrounding tissues?

A: No, this is one of the benefits of Oraqix, it will not cause numbness to the surrounding tissues, including lips and tongue.

Q: How quickly will the effects of Oraqix wear off?

A: The duration of anesthesia is about 20 minutes (individual overall range 14-31 minutes), though this can differ between patients.

Q: Is Oraqix contraindicated for any patient groups?

A: Prilocaine can cause elevated methemoglobin levels particularly in conjunction with methemoglobin-inducing agents. Methemoglobinemia has also been reported in a few cases in association with lidocaine treatment.

Patients with glucose-6-phosphate dehydrogenase deficiency or congenital or idiopathic Methemoglobinemia are more susceptible to drug-induced MethemoglobinemiA:

Oraqix should not be used in those patients with congenital or idiopathic Methemoglobinemia and in infants under the age of twelve months who are receiving treatment with methemoglobin-inducing agents.

Patients taking drugs associated with drug-induced Methemoglobinemia such as sulfonamides, acetaminophen, acetanilide, aniline dyes, benzocaine, chloroquine, dapsone, naphthalene, nitrates and nitrites, nitrofurantoin, nitroglycerin, nitroprusside, pamaquine, para-aminosalicylic acid, phenacetin, phenobarbitol, phenytoin, primaquine, and quinine are at greater risk for developing methemoglobinemiA:

Q: What are the side effects of Oraqix?

A: The most common adverse reactions in clinical studies were application site reactions, headaches, and taste preversion.

To read more detailed answers to frequently asked questions regarding our dental services, please click on the badges below.